|
Match
|
Document |
Document Title |
|
|
7622482 |
Chemical compounds
This invention relates to novel compounds having the formula (I): and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.
|
|
|
7589097 |
Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists
The use of a compound of formula (I):
wherein
R 1 is selected from H, alkyl, aryl, alkoxy, aryloxy, alkylthio, arylthio, halogen, CN, NR 5 R 6 , NR 4 COR 5 , NR 4 CONR 5 R 6 , NR 4 CO 2 R 7 ...
|
|
|
7566722 |
Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists
The present invention is directed to novel bicyclic triazolopyrimidine compounds of Formula (I) or a form thereof:
wherein R 1 and R 2 are as defined herein, and their methods of preparation...
|
|
|
7563781 |
Triazolopyrimidine derivatives
The invention relates to the discovery of triazolopyrimidine derivatives of formula (I), which have been found to exhibit inhibitory activity against the serine-tyrosine and tyrosine kinases.
|
|
|
7560458 |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
This invention concerns compounds of formula
N-oxides, pharmaceutically acceptable addition salts, quaternary amines and stereochemically isomeric forms thereof, their use, pharmaceutical...
|
|
|
7407962 |
Heteroaryl compounds useful as inhibitors or protein kinases
The present invention provides compounds that are inhibitors of protein kinase, particularly inhibitors of ERK2, GSK3, PKA, CDK2 protein kinases, mammalian protein kinases involved in proliferative...
|
|
|
7345047 |
Substituted [1,2,3]triazolo[4,5-d]pyrimidines
The invention provides novel substituted cyclopentane compounds (in particular, substituted [1,2,3]triazolo[4,5-d]pyrimidines), their use as medicaments (in particular, their use as anti-thrombotic...
|
|
|
7339058 |
Process for the preparation of N-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides
The N-arylsulfilimine-catalyzed coupling of aromatic sulfonyl chlorides with N-([1,2,4]triazolopyrimidin-2-yl)amines to form N-([1,2,4]triazolo-pyrimidin-2-yl)aryl sulfonamides is improved by the...
|
|
|
7265124 |
Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound
The invention provides new forms of a chemical compound of formula (I). The invention relates to forms of a chemical compound (I), in particular to crystalline and amorphous forms, more...
|
|
|
7250419 |
Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
|
|
|
7129244 |
Triazolopyrimidines and related analogs as HSP90-inhibitors
A compound represented by Formula I, or a polymorph, ester, tautomer, enantiomer, diastereomer, pharmaceutically acceptable salt or prodrug thereof,
Wherein R 1 is halogen, —OR 11 , —SR 11...
|
|
|
7115739 |
Triazole compounds useful as protein kinase inhibitors
This invention describes novel triazole compounds of formula IX:
wherein Z 1 is nitrogen or CR 9 and Z 2 is nitrogen or CH, provided that at least one of Z 1 and Z 2 is nitrogen; G is Ring...
|
|
|
7074929 |
Certain alkylene diamine-substituted heterocycles
This invention relates to novel compounds, compositions, and methods for the treatment of physiological disorders associated with an excess of neuropeptide Y. The novel compounds encompassed by the...
|
|
|
7067663 |
Triazolo pyrimidine compounds
Pyrimidine compound (I)
useful as a pharmaceutical intermediate, a process for preparing the pyrimidine compound (I), to intermediates used in the process, and use of the pyrimidine...
|
|
|
7034032 |
Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compounds
The invention provides novel 1,2,3-triazolo[4,5-d]pyrimidine compounds, such as those represented by formula (I):
their use as medicaments, particularly in platelet aggregation disorders,...
|
|
|
6974868 |
Compounds
The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
|
|
|
6858616 |
Nitrogen containing heterobicycles as factor Xa inhibitors
The present application describes nitrogen containing heterobicyclics and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.
|
|
|
6844348 |
2,3,4-cyclopentan-2,3,4-triol-1-yl compounds
The invention provides a compound of formula (I):
wherein R 1 is alkyl C 1-6 or alkenyl C 2-6 , both independently optionally substituted by one or more groups selected from alkyl C 1-5 or...
|
|
|
6790841 |
2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents
Compounds which are active against viruses have the following Formulas: wherein B is a purine or pyrimidine heterocyclic ring and is preferably selected from the group consisting of...
|
|
|
6767910 |
Triazolo&lsqb 4,5-d&rsqb pyrimidinyl compounds
Compounds of the formula (I) and their use as anti-platelet aggregation compounds.
|
|
|
6734180 |
NF-&kgr B inhibitor comprising an indan derivative as an active ingredient
An inhibitor of NF-κB comprising as an active ingredient an indan derivative represented by the general formula (I) or a salt thereof.
|
|
|
6713483 |
&lsqb 1,2,3&rsqb -triazolo&lsqb 4,5-d&rsqb pyrimidine compounds
The invention provides [1,2,3]-triazolo[4,5-d]pyrimidine analogue compounds of formula (I) The invention is also directed to pharmaceutical compositions containing the compounds, processes for...
|
|
|
6645965 |
Nitrate salts of antihypertensive medicines
Nitric acid salts with medicines having an antihypertensive activity.
|
|
|
6635647 |
Decahydro-isoquinolines
The invention provides compounds of formula (I) wherein A, B and R are as defined herein and the preparation thereof. The compounds of formula (I) are useful as somatostatin antagonists.
|
|
|
6525060 |
Triazolo(4,5-d)pyrimidine compounds
Triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation. The compounds of the invention have the formula (I) as follows: ...
|
|
|
6525056 |
Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders
Corticotropin releasing factor (CRF) antagonists of Formula (I): and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress...
|
|
|
6458950 |
Compounds and pharmaceutical compositions containing the same
A compound shown by the formula II, wherein Het is a mono- or polycyclic heterocyclic group comprising one or more hetero atoms selected from the group consisting of N, O and S which may be the...
|
|
|
6458796 |
Dihydro-&lsqb 1,2,3&rsqb triazolo-&lsqb 4,5-d&rsqb pyrimidin-7-one
The present invention relates to novel dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one, to processes for their preparation and to their use as medicaments, in particular as inhibitors of...
|
|
|
6455322 |
Competition binding assay for detecting P2YADP receptor ligands
The invention provides a competition binding assay for detecting P2Y ADP receptor ligands.
|
|
|
6436945 |
Substituted O6-benzyl-8-aza-guanines
The present invention provides AGT inactivating compounds, for example, substituted O 6 -benzyl-8-aza-guanines of the formula wherein R, for example, is pivaloyloxymethyl as well as...
|
|
|
6423716 |
Nitrogenous heterocyclic compounds
The present invention relates to nitrogen-containing heterocyclic compounds represented by formula (I): wherein W represents 1,4-piperazinediyl, etc.; U represents NR 1 R 2 (wherein R 1 ...
|
|
|
6376667 |
Solid phase synthesis of heterocycles
Methods and compounds for the synthesis of heterocycles, including pyrimidine-2,4-diones, are disclosed. Also disclosed are solid supports useful for solid phase synthesis, and methods for making...
|
|
|
6369064 |
Triazolo(4,5-d)pyrimidine compounds
Triazolo[4,5-d]pyrimidine compounds are provided of the formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as defined in the specification. Compositions containing the compounds are...
|
|
|
6297232 |
Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments
The invention relates to triazolo[4,5-d]pyrimidin-3-yl derivatives which are useful in the treatment of platelet aggregation disorders.
|
|
|
6251910 |
1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists
Compounds of formula having the following stereochemistry ##STR1## wherein R, R 1 , R 2 , R 3 and R 4 are as defined in the specification. The compounds are useful as P 2T receptor antagonists.
|
|
|
RE37234 |
Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
Disclosed are nitrosated and/or nitrosylated phosphodiesterase inhibitors having the formula NO n -PDE inhibitor where n is 1 or 2. The invention also provides compositions comprising such...
|
|
|
6165942 |
Heterocycle-fused pyrimidinone derivative and herbicidal composition
A compound represented by the general formula (I) and a salt thereof: ##STR1## wherein: Rf represents a (C 1 -C 4 )haloalkyl group; X.about.Y represents NN or CHN or the like; A represents a...
|
|
|
6156766 |
Benzamide compounds and pharmaceutical use thereof
Benzamide compounds of the formula ##STR1## wherein each symbol is defined in the specification, isomers thereof and pharmaceutically acceptable acid addition salts thereof. Pharmaceutical...
|
|
|
6156756 |
Triazolo [4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation
The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
|
|
|
6124300 |
Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives
Novel compounds and pharmaceutical compositions thereof, and methods of using same in treating anxiety, depression, and other psychiatric and neurological disorders. The novel compounds provided by...
|
|
|
6107300 |
Arylamino fused pyrimidines
Corticotropin releasing factor (CRF) antagonists of formula I or formula II: ##STR1## and their use in treating anxiety, depression, and other psychiatric and neurological disorders.
|
|
|
6046207 |
Benzopyranopyrrole and benzopyranopyridine α-1 adrenergic compounds
The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a bicyclic heterocyclic ring system. The compounds are α-1 adrenergic...
|
|
|
6030973 |
Heterocyclic compounds having antidiabetic hypolipidemia and antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their analogues, their stereoisomers, their polymorphs, their pharmaceutically acceptable...
|
|
|
5962684 |
Method of preparation of dideoxycarbocyclic nucleosides
A therapeutic method is provided, employing an antiviral compound of the general formula: ##STR1## wherein Z is H, OR' or N(R) 2 , wherein R' is H, (C 1 -C 4 )alkyl, aryl, CHO, (C 1 -C 16...
|
|
|
5929079 |
Trans cyclopentanyl azaadenyl analogs useful as immunosuppressants
This invention relates to Trans cyclopentanyl purine analogs of the formula (1) ##STR1## wherein the substituent in the 3-position on the cyclopentanyl ring is in the Trans configuration relative...
|
|
|
5880129 |
Methods of inhibiting invasion and metastasis of malignant solid tumors
A discovery underlying this invention is the concordance between particular cellular signaling mechanisms and cancer cell growth and metastasis. It has now been discovered that certain compounds...
|
|
|
5869659 |
Heteroatom-containing cyclopentanopyridyl-oxazolidinones
The present invention relates to heteroatom-containing cyclopentanopyridyl-oxazolidinones, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.
|
|
|
5807854 |
Pyrimidone derivatives with antifungal activity
Compounds of general formula I and their salts and solvates are antifungal agents and as such are useful in the treatment of various fungal infections. Pharmaceutical compositions including these...
|
|
|
5763608 |
Process for preparing pyrimidine derivatives
The present invention provides a process for preparing a 5,6-dihydro-3H-pyrimidin-4-one derivatives which comprises the steps of (a) dehydrating a N-acyl beta amino acid in the presence of a...
|
|
|
5747496 |
Inhibitors of platelet aggregation
Compounds of the formula (I) ##STR1## wherein B is O or CH 2 ; X is selected from NR 1 R 2 , SR 1 , and C 1 -C 7 alkyl; Y is selected SR 1 , NR 1 R 2 , and C 1 -C 7 alkyl; R 1 and...
|